Literature DB >> 34219784

Sabulous cystitis in the horse: 13 cases (2013-2020).

Luiza S Zakia1, Diego E Gomez1, Daniel G Kenney1, Luis G Arroyo1.   

Abstract

The objective of this study was to describe the clinical findings, medical management, and outcomes of horses with sabulous cystitis, and to describe a high flow bladder lavage procedure in horses that are standing or under general anesthesia. The medical records of 13 horses diagnosed with sabulous cystitis via cystoscopy between 2013 and 2020 were reviewed. Geldings (92%) and Warmbloods (46%) were overrepresented. The most common presenting complaint was urinary incontinence (69%). Complete blood cell count, serum biochemistry profile and urine cytology results were non-specific. Six (46%) horses had various degrees of erosion, ulceration, and hemorrhage of the bladder mucosa. All horses were treated with bladder lavage either with standing sedation (n = 12) or general anesthesia (n = 2), as well as antimicrobials (54%), anti-inflammatory drugs (62%), bethanechol (15%), and phenazopyridine (15%). Most horses (85%) were discharged from the hospital, but only a small percentage (23%) was reported as having no urinary abnormalities on follow-up communication. Key clinical message: Copious bladder lavage with a high flow rate system could mitigate the acute clinical signs and improve the quality of life of horses with sabulous cystitis, but the prognosis for return to previous level of athletic performance and long-term survival is guarded. Copyright and/or publishing rights held by the Canadian Veterinary Medical Association.

Entities:  

Mesh:

Year:  2021        PMID: 34219784      PMCID: PMC8218954     

Source DB:  PubMed          Journal:  Can Vet J        ISSN: 0008-5286            Impact factor:   1.008


  13 in total

1.  Bethanechol-responsive bladder atony in a colt foal after cystorrhaphy for cystorrhexis.

Authors:  T M Booth; D A Howes; G B Edwards
Journal:  Vet Rec       Date:  2000-09-09       Impact factor: 2.695

2.  Long-term management of sabulous cystitis in five horses.

Authors:  D I Rendle; A E Durham; K J Hughes; D Lloyd; G E S Summerhays
Journal:  Vet Rec       Date:  2008-06-14       Impact factor: 2.695

3.  In vitro effects of bethanechol on equine gastrointestinal contractility and functional characterization of involved muscarinic receptor subtypes.

Authors:  M Marti; M Mevissen; H Althaus; A Steiner
Journal:  J Vet Pharmacol Ther       Date:  2005-12       Impact factor: 1.786

4.  Peculiarities of vitamin D and of the calcium and phosphate homeostatic system in horses.

Authors:  A Breidenbach; C Schlumbohm; J Harmeyer
Journal:  Vet Res       Date:  1998 Mar-Apr       Impact factor: 3.683

5.  Ten cases of bladder paralysis associated with sabulous urolithiasis in horses.

Authors:  P E Holt; T S Mair
Journal:  Vet Rec       Date:  1990-08-04       Impact factor: 2.695

6.  Crystalline composition of equine urinary sabulous deposits.

Authors:  M Diaz-Espineira; E Escolar; J Bellanato; J A Medina
Journal:  Scanning Microsc       Date:  1995

Review 7.  Phenazopyridine associated acute interstitial nephritis and review of literature.

Authors:  Manisha Singh; Fnu Shailesh; Upasana Tiwari; Shree G Sharma; Bilal Malik
Journal:  Ren Fail       Date:  2014-02-27       Impact factor: 2.606

8.  Urolithiasis in the horse - a review of 13 cases.

Authors:  P E Holt; H Pearson
Journal:  Equine Vet J       Date:  1984-01       Impact factor: 2.888

9.  A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate versus dimethyl sulfoxide in women with bladder pain syndrome/interstitial cystitis.

Authors:  Mauro Cervigni; Monica Sommariva; Raffaele Tenaglia; Daniele Porru; Edoardo Ostardo; Alessandro Giammò; Silvia Trevisan; Valeria Frangione; Oriana Ciani; Rosanna Tarricone; Giovanni L Pappagallo
Journal:  Neurourol Urodyn       Date:  2016-09-21       Impact factor: 2.696

10.  Equine idiopathic hemorrhagic cystitis: Clinical features and comparison with bladder neoplasia.

Authors:  Fauna L Smith; K Gary Magdesian; Adam O Michel; Betsy Vaughan; Christopher M Reilly
Journal:  J Vet Intern Med       Date:  2018-03-31       Impact factor: 3.333

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.